A Phase I/II Trial of Protease Inhibitor, Nelfinavir, Given With Concurrent Thoracic Chemoradiotherapy in Patients With Locally-Advanced Non-Small Cell Lung Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Etoposide; Nelfinavir
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Biomarker
- 24 Apr 2020 Biomarkers information updated
- 06 Feb 2008 New trial record.